Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- RS -6.6%, CMG -2.4%, (reaffirms/clarifies guidance for certain financial and operating results for Q2/FY17)
Other news:
- AVXS -5.6% ( to offer up to $200 million of shares of its common stock in an underwritten public offering)
- FDUS -3.1% ( commences public offering of 1.5 mln shares of its common stock)
- GLPG -2.4% (provides and update for its R&D program)
- NEOS -1.6% (co received FDA approval for Cotempla XR-ODT )
- BT -1.2% (Orange completes the sale of BT (BT) shares)
- BCS -0.9% (Serious Fraud Office issues charges against Barclays regarding capital raisings in 2008)
Analyst comments:
- CSOD -1.7% (downgraded to Underweight from Equal Weight at Barclays)
- ADP -1.5% (downgraded to Neutral at Goldman; Removed from Conviction Buy List)
- PAYX -1.1% (downgraded to Neutral from Buy at Goldman)
- ON -1.1% (downgraded to Sector Weight from Overweight at Pacific Crest)